Shareholders' equity · 2011–2025
Acadia Pharmaceuticals shareholders' equity
$1.2B+67.5% · FY2025
Acadia Pharmaceuticals (ACAD) reported $1.2B in shareholders' equity for fiscal 2025, +67.5% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.2B | +67.5% | Open → |
| FY20242024-12-31 | $733M | +69.7% | Open → |
| FY20232023-12-31 | $432M | +7.8% | Open → |
| FY20222022-12-31 | $400M | −26.0% | Open → |
| FY20212021-12-31 | $541M | −13.7% | Open → |
| FY20202020-12-31 | $627M | −10.3% | Open → |
| FY20192019-12-31 | $699M | +45.9% | Open → |
| FY20182018-12-31 | $479M | +42.9% | Open → |
| FY20172017-12-31 | $335M | −35.3% | Open → |
| FY20162016-12-31 | $518M | +159.5% | Open → |
| FY20152015-12-31 | $200M | −35.5% | Open → |
| FY20142014-12-31 | $309M | +69.9% | Open → |
| FY20132013-12-31 | $182M | +114.3% | Open → |
| FY20122012-12-31 | $85.0M | +263.8% | Open → |
| FY20112011-12-31 | $23.4M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +32.7%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Acadia Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/acadia-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Acadia Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/acadia-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-acadia-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Acadia Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/acadia-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-333243 · August 5, 2026
{{cite web |title=Acadia Pharmaceuticals shareholders' equity — 10-Q (0001193125-26-333243) |url=https://www.sec.gov/Archives/edgar/data/1070494/000119312526333243/acad-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.